Pathological complete response (pCR) after neoadjuvant therapy is achieved in only about 20%–40% of patients with locally advanced esophageal cancer (LAEC), yet it is the strongest determinant of long-term survival.
18
F-fluorodeoxyglucose (
18
F-FDG) positron emission tomography/computed tomography (PET/CT)...
Jie Li, S. Suppiah, Lingeswaran Kasilingam et al.· Frontiers in Medical Enginee...· 0 citations
Background/Objectives: Androgen receptor pathway inhibitor (ARPI) intensification in metastatic hormone-sensitive prostate cancer has changed the population reaching metastatic castration-resistant prostate cancer (mCRPC), and the optimal sequence of subsequent therapies is uncertain. Methods: The study presents a narr...
B. Sharaf, M. Al-Rwashdeh, O. El Khatib et al.· Cancers· 0 citations
Oncocytic thyroid carcinoma (OTC) and tenosynovial giant cell tumor (TGCT) are rare neoplasms with distinct biological behavior, and their coexistence has not been previously well documented. We report a rare case of concurrent recurrent OTC and diffuse-type TGCT (TGCT-D) in a 45-year-old man who presented with a rapid...
Fatimah AbuAlJaaz, Mahd Foqhaa, M. Abed et al.· Asia Oceania Journal of Nucl...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.